Results 111 to 120 of about 24,815 (217)

In vitro anticoagulant activity of crude fibrinolytic protease HSFT-2 as an alternative anticoagulant agent

Indonesian Journal of Medical Laboratory Science and Technology
Thrombotic disorders are one of the leading causes of death in cardiovascular patients and contribute to the incidence of non-infectious diseases. The search for new anticoagulant agents to overcome the limitations associated with existing anticoagulant
Muhammad Ardi Afriansyah, Toeti Rahajoe, Raksi Pranindira   +2 more
doaj   +1 more source

Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. [PDF]

Cochrane Database Syst Rev, 2019
Altmann ES, Crossingham I, Wilson S, Davies HR.   +3 more
europepmc   +1 more source

Oral fibrinolytic agent in hyper-coagulopathy in severe COVID – 19 ARDS Patients: two case reports

Journal of the Pakistan Medical Association
The use of oral fibrinolytic agent (DLBS1033) has been proven for adjuvant treatment in venous thromboembolism, however until now there is no published report about its uses and effectiveness as an addition to the standard therapy of severe COVID-19 ...
Dimas Rio Balti, Liem Audi Natalino, Armyta Galuh, Ryan Enast Intan   +3 more
doaj   +1 more source

Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages. [PDF]

J Cereb Blood Flow Metab, 2018
Goulay R, Naveau M, Gaberel T, Vivien D, Parcq J.   +4 more
europepmc   +1 more source

In-vitro and in-silico analyses of the thrombolytic potential of green kiwifruit

Scientific Reports
Cardiovascular diseases (CVDs), mainly caused by thrombosis complications, are the leading cause of mortality worldwide, making the development of alternative treatments highly desirable.
Reinhard Pinontoan, Jonathan Suciono Purnomo, Elvina Bella Avissa, Jessica Pricilla Tanojo, Moses Djuan, Valerie Vidian, Ariela Samantha, Juandy Jo, Eden Steven   +8 more
doaj   +1 more source

Genipin-crosslinked gelatin microspheres as a strategy to prevent postsurgical peritoneal adhesions : in vitro and in vivo characterization [PDF]

, 2016
Bracke, Marc, Ceelen, Wim, De Clercq, Kaat, De Wever, Olivier, Remon, Jean Paul, Schelfhout, Charlotte, Van Bockstal, Mieke, Vervaet, Chris   +7 more
core   +1 more source

Once-daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients [PDF]

, 2010
In this paper, we describe our experience in the treatment of childhood empyema using urokinase. Patients' ages ranged from 2 to 12 years. Urokinase (dosage: 3,100 IU/kg/day) was diluted in normal saline to produce 1000 IU/ml (maximum dosage 100,000 IU ...
Bergamini, Barbara Maria, Bianchini, M. A., Biondini, D., Cacciari, A., Ceccarelli, P. L., Durante, V., Repetto, P.   +6 more
core  

Biochemistry and applications of Aprotimin, the kallikrein inhibitor from bovine organs. [PDF]

, 1985
Fritz, Hans, Wunderer, G.
core   +1 more source

Comparison of Door to Needle Times for Three Fibrinolytic Strategies in Acute Ischemic Stroke. [PDF]

Hosp Pharm
Pyles D, Friery E, Ponce A, Quedado J, Zarfoss Ponce E.   +4 more
europepmc   +1 more source

Case report: Can fibrinolytics effectively manage gross hematuria and clot retention in an elderly patients, leading to the diagnosis of lymphoma? [PDF]

Urol Case Rep
Bighamian M, Jamadi MS, Dorostkar A, Rajaee Rizi F.   +3 more
europepmc   +1 more source